HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bridges Consumer Startup Reaches Brands For Specialty Conditions In Clarion Deal

Executive Summary

Acquiring Clarion Brands from Swander Pace, Bridges Consumer Healthcare adds portfolio of OTC and supplement brands for symptoms including tinnitus, urinary pain relief and excessive sweating.

You may also be interested in...



Pharmavite Moves Into OTCs With Uqora Acquisition To Expand Women’s Health Lineup

Pharmavite acquires Uqora, a startup marketing supplements, OTCs and devices to prevent or treat urinary tract infections. Moving into the category adds a growth driver as UTIs are the most common bacterial infection requiring medical care in the US.

HBW Market Executive Decisions: C&D, Bridges Consumer, DSM Nutrition, CRN Board Chair

Bruno at Church & Dwight international helm; Chattem executives Long, Ramey launch Bridges Consumer; Atrium’s Ritz starts as CRN chairman; and DSM Nutritional Products chief Goppelsroeder leaving.

Top 20 Consumer Health Deals 2020: Private Equity And OTC Exits Drive M&A

HBW Insight reveals the biggest consumer health deals of 2020, and identifies growing private equity investment, portfolio streamlining by major players and pharma firms exiting OTC as the major drivers of M&A activity.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150920

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel